Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,405 | -15,189 | -11,047 | -3,803 | -1,921 |
| Depreciation Amortization | 173 | 293 | 375 | 233 | 113 |
| Accounts receivable | -115 | -1,814 | -1,958 | -2,368 | -1,077 |
| Other Working Capital | -359 | -1,135 | -2,086 | -1,803 | -723 |
| Other Operating Activity | 789 | 9,548 | 8,009 | 3,793 | 1,778 |
| Operating Cash Flow | $-2,917 | $-8,297 | $-6,707 | $-3,948 | $-1,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32 | -46 | -33 | N/A | N/A |
| Other Investing Activity | 0 | 481 | 481 | 192 | 0 |
| Investing Cash Flow | $-32 | $435 | $448 | $192 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,395 | N/A | 1,261 | 1,311 | 590 |
| Debt Issued | N/A | 24 | 50 | N/A | N/A |
| Debt Repayment | -8 | N/A | -18 | -9 | -4 |
| Common Stock Issued | 718 | 4,791 | 3,731 | 2,397 | 280 |
| Other Financing Activity | 85 | 3,406 | 2,245 | 0 | 0 |
| Financing Cash Flow | $3,190 | $8,221 | $7,269 | $3,699 | $866 |
| Exchange Rate Effect | -2 | -24 | -12 | -20 | -20 |
| Beginning Cash Position | 3,883 | 3,548 | 3,548 | 3,548 | 3,548 |
| End Cash Position | 4,122 | 3,883 | 4,546 | 3,471 | 2,564 |
| Net Cash Flow | $239 | $335 | $998 | $-77 | $-984 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,917 | -8,297 | -6,707 | -3,948 | -1,830 |
| Capital Expenditure | -32 | -46 | -33 | N/A | N/A |
| Free Cash Flow | -2,949 | -8,343 | -6,740 | -3,948 | -1,830 |